Your browser doesn't support javascript.
loading
Wide Variability in Dysplasia Detection Rate and Adherence to Seattle Protocol and Surveillance Recommendations in Barrett's Esophagus: A Population-Based Analysis Using the GIQuIC National Quality Benchmarking Registry.
Kolb, Jennifer M; Davis, Christian; Williams, J Lucas; Holub, Jennifer; Shaheen, Nicholas; Wani, Sachin.
Afiliación
  • Kolb JM; Division of Gastroenterology, Hepatology and Parenteral Nutrition, VA Greater Los Angeles Healthcare System, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Davis C; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Williams JL; GI Quality Improvement Consortium, Bethesda, Maryland, USA.
  • Holub J; GI Quality Improvement Consortium, Bethesda, Maryland, USA.
  • Shaheen N; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Wani S; Division of Gastroenterology and Hepatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Am J Gastroenterol ; 118(5): 900-904, 2023 05 01.
Article en En | MEDLINE | ID: mdl-36623168
ABSTRACT

INTRODUCTION:

Variability in adherence rates to the Seattle protocol and to surveillance interval recommendations, established quality indicators (QIs) in Barrett's esophagus (BE), is unknown.

METHODS:

We evaluated endoscopist and site-based adherence rates to these QIs from January 2018 to May 2021 using the GI Quality Improvement Consortium national registry with matched endoscopy and pathology data.

RESULTS:

Across 153 practices with 572 endoscopists performing 20,155 endoscopies, adherence to the Seattle protocol varied by endoscopists (median 93.8%, IQR 18.9%) and by site (median 90.0%, IQR 20.1%). Adherence to appropriate surveillance intervals for nondysplastic BE also varied by endoscopist (median 82.4%, IQR 36.3%) and site (median 77.2%, IQR 29.8%). The overall dysplasia detection rate was 3.1% and varied among endoscopists and sites.

DISCUSSION:

These US population-based results can serve as a benchmark for quality initiatives and intervention trials aimed at improving outcomes for patients with BE.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esófago de Barrett / Neoplasias Esofágicas Tipo de estudio: Diagnostic_studies / Guideline / Screening_studies Límite: Humans Idioma: En Revista: Am J Gastroenterol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esófago de Barrett / Neoplasias Esofágicas Tipo de estudio: Diagnostic_studies / Guideline / Screening_studies Límite: Humans Idioma: En Revista: Am J Gastroenterol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos